Your Leading Source of Intelligence into the Business of Biotechnology
GEN Edge is biotech’s leading source of business, science, and company news, including emerging research and drug discovery technologies impacting new therapeutic development and investment decisions. Our team of talented GEN Edge reporters deliver deep market intelligence and engaging thought leader interviews with biotech Movers and Shakers that go beyond the headlines to give you early insights into how, when, and why the latest developments are driving the future of the biotech industry.
GEN Edge subscribers across corporate and academic life sciences use our compelling editorial stories to maintain a competitive advantage and make informed business decisions that lead their organizations to innovation and success.
A subscription with GEN Edge grants you insider access to a host of subscriber-only content including breaking news, in-depth reporting, broadcast shows, video series, profiles of groundbreaking companies, market analyses, and access to live events.
Unlock Premium Subscriber Benefits
For only $18 a month*, GEN Edge delivers:
*With an annual subscription.